Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medicinal Chemistry
  4. Volume 32, Issue 7
  5. Article
Volume 32, Issue 7
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background

Kisspeptin was initially known as metastin for its role in suppressing metastasis in melanoma and breast cancer. Later, based on its ability to stimulate GPR54, its importance in maintaining an intact hypothalamic-pituitary-ovarian axis was recognised, which is the basis for the widespread application of the drug in several conditions such as secondary amenorrhea, regulation of puberty onset, ovarian function, trophoblast invasion, fertility regulation, parturition, and lactation. This systematic study aims to evaluate the current status of kisspentin in clinical trials.

Methods

The keywords 'kisspeptin' or 'metastin' were used in the clinicaltrials.gov website and Clinical Trial Registry of India (CTRI) to find eligible clinical trials or records carried out without time constraints until February 26, 2023.

Results

A total of 33 records were identified through clinical trial databases. All records were screened, and four trials were rejected as they failed to meet the inclusion criteria. Finally, 29 (87.9%) reports of interventional clinical trials with kisspeptin were reviewed.

Conclusion

Kisspeptin can be viewed as a multipurpose drug with considerably fewer side effects due to its effects simulating normal physiological processes in our body.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673251224230919093656
2023-11-27
2025-04-23

  • From This Site

    /content/journals/cmc/10.2174/0109298673251224230919093656
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. TakahashiK. ShojiI. ShibasakiA. KatoI. HiraishiK. YamamotoH. KanekoK. MurakamiO. MorimotoR. SatohF. ItoS. TotsuneK. Presence of kisspeptin-like immunoreactivity in human adrenal glands and adrenal tumors.J. Mol. Neurosci.201041113814410.1007/s12031‑009‑9306‑419898965
     [Google Scholar]
  2. ClarkeH. DhilloW.S. JayasenaC.N. Comprehensive review on kisspeptin and its role in reproductive disorders.Endocrinol. Metab.201530212414110.3803/EnM.2015.30.2.12426194072
     [Google Scholar]
  3. TsoutsoukiJ. PatelB. ComninosA.N. DhilloW.S. AbbaraA. Kisspeptin in the prediction of pregnancy complications.Front Endocrinol.20221394266410.3389/fendo.2022.942664
     [Google Scholar]
  4. MeczekalskiB. NiwczykO. BalaG. SzeligaA. Stress, kisspeptin, and functional hypothalamic amenorrhea.Curr. Opin. Pharmacol.20226710228810.1016/j.coph.2022.10228836103784
     [Google Scholar]
  5. TrevisanC.M. MontagnaE. de OliveiraR. ChristofoliniD.M. BarbosaC.P. CrandallK.A. BiancoB. Kisspeptin/GPR54 system: What do we know about its role in human reproduction?.Cell. Physiol. Biochem.20184941259127610.1159/00049340630205368
     [Google Scholar]
  6. RometoA.M. KrajewskiS.J. Lou VoytkoM. RanceN.E. Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys.J. Clin. Endocrinol. Metab.20079272744275010.1210/jc.2007‑055317488799
     [Google Scholar]
  7. U.S National Library of Medicine. Available at: https://www.clinicaltrials.gov/ (Assessed on: Feb 26, 2023).
     [Google Scholar]
  8. Clinical Trial Registry of India. Available at: https://ctri.nic.in/Clinicaltrials/login.php (Assessed on: Feb 26, 2023).
     [Google Scholar]
  9. HarterC.J.L. KavanaghG.S. SmithJ.T. The role of kisspeptin neurons in reproduction and metabolism.J. Endocrinol.20182383R173R18310.1530/JOE‑18‑010830042117
     [Google Scholar]
  10. LeeJ-H. MieleM.E. HicksD.J. PhillipsK.K. TrentJ.M. WeissmanB.E. WelchD.R. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene.J. Natl. Cancer Inst.199688231731173710.1093/jnci/88.23.1731
     [Google Scholar]
  11. OakleyA.E. CliftonD.K. SteinerR.A. Kisspeptin signaling in the brain.Endocr. Rev.200930671374310.1210/er.2009‑000519770291
     [Google Scholar]
  12. WestA. VojtaP.J. WelchD.R. WeissmanB.E. Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1).Genomics.199854114514810.1006/geno.1998.55669806840
     [Google Scholar]
  13. SkorupskaiteK. GeorgeJ.T. AndersonR.A. The kisspeptin-GnRH pathway in human reproductive health and disease.Hum. Reprod. Update.201420448550010.1093/humupd/dmu00924615662
     [Google Scholar]
  14. ComninosA.N. HansenM.S. CourtneyA. ChoudhuryS. YangL. MillsE.G. PhylactouM. BusbridgeM. KhirM. ThaventhiranT. BechP. TanT. AbbaraA. FrostM. DhilloW.S. Acute effects of kisspeptin administration on bone metabolism in healthy men.J. Clin. Endocrinol. Metab.202210761529154010.1210/clinem/dgac11735244717
     [Google Scholar]
  15. ThurstonL. HunjanT. ErtlN. Effects of kisspeptin administration in women with hypoactive sexual desire disorder: A randomized clinical trial.JAMA Netw. Open.2022510e223613110.1001/jamanetworkopen.2022.36131
     [Google Scholar]
  16. d’Anglemont de TassignyX. ColledgeW.H. The role of kisspeptin signaling in reproduction.Physiology.201025420721710.1152/physiol.00009.201020699467
     [Google Scholar]
  17. de RouxN. GeninE. CarelJ.C. MatsudaF. ChaussainJ.L. MilgromE. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.Proc. Natl. Acad. Sci. USA.200310019109721097610.1073/pnas.183439910012944565
     [Google Scholar]
  18. RevelF.G. SaboureauM. Masson-PévetM. PévetP. MikkelsenJ.D. SimonneauxV. Kisspeptin mediates the photoperiodic control of reproduction in hamsters.Curr. Biol.200616171730173510.1016/j.cub.2006.07.02516950111
     [Google Scholar]
  19. MerkleyC.M. CoolenL.M. GoodmanR.L. LehmanM.N. Evidence for changes in numbers of synaptic inputs onto KNDy and GnRH neurones during the preovulatory lh surge in the ewe.J. Neuroendocrinol.201527762463510.1111/jne.1229325976424
     [Google Scholar]
  20. ScottC.J. RoseJ.L. GunnA.J. McGrathB.M. Kisspeptin and the regulation of the reproductive axis in domestic animals.J. Endocrinol.2018JOE-180485.R110.1530/JOE‑18‑0485
     [Google Scholar]
  21. NimriR. LebenthalY. LazarL. ChevrierL. PhillipM. BarM. Hernandez-MoraE. de RouxN. Gat-YablonskiG. A novel loss-of-function mutation in GPR54/KISS1R leads to hypogonadotropic hypogonadism in a highly consanguineous family.J. Clin. Endocrinol. Metab.2011963E536E54510.1210/jc.2010‑167621193544
     [Google Scholar]
  22. SharmaA. ThaventhiranT. MinhasS. DhilloW.S. JayasenaC.N. Kisspeptin and testicular function-is it necessary?.Int. J. Mol. Sci.2020218295810.3390/ijms21082958
     [Google Scholar]
  23. MunroM.G. CritchleyH.O.D. FraserI.S. The FIGO classification of causes of abnormal uterine bleeding.Int. J. Gynaecol. Obstet.201111311210.1016/j.ijgo.2011.01.00121316671
     [Google Scholar]
  24. MillsE.G. ErtlN. WallM.B. Effects of kisspeptin on sexual brain processing and penile tumescence in men with hypoactive sexual desire disorder: A randomized clinical trial.JAMA Netw. Open.202362e225431310.1001/jamanetworkopen.2022.54313
     [Google Scholar]
  25. CintraR.G. WajnsztejnR. TrevisanC.M. ZaiaV. LaganàA.S. BiancoB. MontagnaE. Kisspeptin levels in girls with precocious puberty: A systematic review and meta-analysis.Horm. Res. Paediatr.20209311-1258959810.1159/00051566033887744
     [Google Scholar]
  26. HuK.L. ChenZ. DengW. LiX. JuL. YangH. ZhangH. MuL. Diagnostic value of kisspeptin levels on early pregnancy outcome: A systematic review and meta-analysis.Reprod. Sci.202229123365337210.1007/s43032‑022‑00856‑835212930
     [Google Scholar]
  27. ChianeseR. CobellisG. ChioccarelliT. CiaramellaV. MigliaccioM. FasanoS. PierantoniR. MeccarielloR. Kisspeptins, estrogens and male fertility.Curr. Med. Chem.201623364070409110.2174/092986732366616090215543427593959
     [Google Scholar]
  28. SeminaraS.B. MessagerS. ChatzidakiE.E. ThresherR.R. AciernoJ.S.Jr ShagouryJ.K. Bo-AbbasY. KuohungW. SchwinofK.M. HendrickA.G. ZahnD. DixonJ. KaiserU.B. SlaugenhauptS.A. GusellaJ.F. O’RahillyS. CarltonM.B.L. CrowleyW.F.Jr AparicioS.A.J.R. ColledgeW.H. The GPR54 gene as a regulator of puberty.N. Engl. J. Med.2003349171614162710.1056/NEJMoa03532214573733
     [Google Scholar]
  29. SilveiraL.G. NoelS.D. Silveira-NetoA.P. AbreuA.P. BritoV.N. SantosM.G. BiancoS.D.C. KuohungW. XuS. GryngartenM. EscobarM.E. ArnholdI.J.P. MendoncaB.B. KaiserU.B. LatronicoA.C. Mutations of the KISS1 gene in disorders of puberty.J. Clin. Endocrinol. Metab.20109552276228010.1210/jc.2009‑242120237166
     [Google Scholar]
  30. PallaisJ.C. Bo-AbbasY. PitteloudN. CrowleyW.F.Jr SeminaraS.B. Neuroendocrine, gonadal, placental, and obstetric phenotypes in patients with IHH and mutations in the G-protein coupled receptor, GPR54.Mol. Cell. Endocrinol.2006254-255707710.1016/j.mce.2006.04.01916757106
     [Google Scholar]
  31. ScottG. AhmadI. HowardK. MacLeanD. OlivaC. WarringtonS. WilbrahamD. WorthingtonP. Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men.Br. J. Clin. Pharmacol.201375238139110.1111/j.1365‑2125.2012.04385.x22803642
     [Google Scholar]
  32. MacLeanD.B. MatsuiH. SuriA. NeuwirthR. ColombelM. Sustained exposure to the investigational Kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: Results from two phase 1 studies.J. Clin. Endocrinol. Metab.2014998E1445E145310.1210/jc.2013‑423624762108
     [Google Scholar]
  33. DhilloW.S. ChaudhriO.B. ThompsonE.L. MurphyK.G. PattersonM. RamachandranR. NijherG.K. AmberV. KokkinosA. DonaldsonM. GhateiM.A. BloomS.R. Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women.J. Clin. Endocrinol. Metab.200792103958396610.1210/jc.2007‑111617635940
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673251224230919093656
Loading
Kisspeptin and its Current Clinical Status-A Systematic Review
Curr. Med. Chem. 32, 1313 (2025); https://doi.org/10.2174/0109298673251224230919093656
/content/journals/cmc/10.2174/0109298673251224230919093656
/content/journals/cmc/10.2174/0109298673251224230919093656
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher's website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): diseases; health services; hospitals; Kisspeptin; metastin; trials

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test